生物活性

Adalimumab is a human monoclonal IgG1 antibody targeting tumour necrosis factor?α (TNF-α).

IC₅₀ & Target

TNF-α

體外研究
(In Vitro)

Treatment of HUVECs with Adalimumab for up to 12 hours shows no adverse effect on their

cell viability, even with a 10-fold higher concentration of Adalimumab than used in this study.

MCE has not independently confirmed the accuracy of these methods. They are for

reference only.

體內研究
(In Vivo)

The elimination half-life (t_1/2) of Adalimumab is long (~20 days). The enriched

fluorescent-labelled adalimumab is observed mainly in major Oil red O-positive lesions

documenting good tissue penetration of the drug into the atherosclerotic plaque, without

background fluorescence of the vessel wall after vehicle control injection into

hypercholesterolemic Ldlr^-/- mice.

MCE has not independently confirmed the accuracy of these methods. They are for

reference only.

分子量

145425.42

CAS 號

331731-18-1

中文名稱

阿達木單抗；阿達莫單抗

運輸條件

Shipping with dry ice.

儲存方式

Please store the product under the recommended conditions in the Certificate of Analysis.